Hinson Introduces Bill to Force Health Insurers to Report Denial Rates, Wait Times

The Bill’s Disclosure Mandate and Its Political Timing

U.S. Rep. Ashley Hinson (R-Iowa) has introduced legislation that would require health insurance companies to publicly report how often they deny or partially deny coverage, how frequently those denials are overturned on appeal, the wait times for coverage decisions, and which treatments need prior authorization. The Health Insurance Transparency for Patients Act does not force insurers to change their practices or limit premiums; instead, it aims to create a consumer-friendly database so patients, employers and physicians can compare plans based on how readily each insurer approves care.

Hinson, who faces a competitive 2026 Senate race, said the bill would expose patterns of insurers denying claims on technicalities to protect profits. The measure has been endorsed by the Iowa Hospital Association and the Iowa Medical Society, which argue that hospitals already face extensive public reporting while insurers operate behind closed doors. However, the bill had no cosponsors as of Thursday and was introduced shortly before Congress’s August recess, leaving just 16 legislative days before the November midterms—making passage unlikely this session.

The proposal arrives as Iowa consumers confront another round of proposed premium increases in the Affordable Care Act marketplace, with average premiums having risen 15.3% for 2026 plans and further hikes expected for 2027. Democrats have criticized Hinson for voting against extending enhanced federal premium tax credits, a move that contributed to a 17% enrollment drop among Iowans with ACA coverage, and argue her transparency bill does little to address immediate affordability concerns. Hinson counters that disclosure is a necessary first step: “You can’t fix a problem you can’t measure.”

What Transparency Data Would (and Wouldn’t) Change for Insurers and Iowans

The Disclosure Mandate’s Practical Impact

The bill requires insurers to report denial rates, appeal overturn frequencies, and prior authorization timeliness, but it lacks any enforcement mechanism. Hinson’s office acknowledged that the data would not directly compel insurers to approve more claims or lower prices; instead, the theory is that transparent metrics will spur competition. Employers shopping for group coverage, and individuals buying on the exchanges, could theoretically favor plans with lower denial rates, putting market pressure on insurers to improve. Whether this dynamic materializes depends on how the data are presented and whether consumers actually use them—many health plan decisions are driven primarily by premium and network, not by denial statistics that may be difficult to interpret.

Transparency vs. Affordability in a Premium Surge

The bill’s narrow focus on disclosure has drawn fire from Democrats who note that Iowa is facing steep premium increases driven by rising medical costs, prescription drug spending, and the expiration of enhanced ACA tax credits. The Iowa Capital Dispatch has reported proposed 2027 increases, while KFF data show that 17% of Iowans with ACA coverage dropped their plans after the enhanced subsidies ended. Hinson’s campaign defends the bill as part of a broader healthcare agenda that also targets pharmacy benefit managers and supports rural hospitals, but the immediate affordability gap remains. For consumers, knowing which insurer denies the most claims won’t lower their monthly bill if all carriers in their area are raising rates.

Political Calculations in an Election Year

The bill serves multiple political purposes in a tight Senate race. It allows Hinson to position herself as a reformer taking on “big health insurance,” countering Democratic attacks over her votes on the ACA and Medicaid. The Iowa Medical Society and hospital group endorsements give her cover from healthcare providers who often clash with insurers over prior authorization. Yet the lack of enforcement teeth and cosponsors suggests the legislation is more a messaging vehicle than a near-term policy win. Hinson’s team says it is the “first step” toward broader accountability measures, and even if the bill stalls, it could lay groundwork for future congressional action should Republicans gain strength.

What This Means for Insurers, Employers and Consumers

• Insurers: Even if this bill does not become law, the push for prior authorization and denial transparency is accelerating at the state and federal levels. Carriers should start auditing their own denial and appeal data now, both to prepare for potential mandates and to identify operational bottlenecks that could become reputation risks if exposed.
• Employers and benefits consultants: When evaluating health plans, request insurer-specific prior authorization and denial metrics at renewal—many insurers already track these internally but don’t share them. The bill’s existence may prompt voluntary disclosure as a competitive differentiator, especially among self-funded plans that can demand such data.
• Consumers: This disclosure-only bill will not reduce your premium for the upcoming enrollment year. Focus on available subsidies, plan networks, and out-of-pocket costs. If the bill advances, the data could eventually help you avoid plans with notoriously high denial rates, but that tool is likely years away.
• Healthcare providers: Hospitals and physician groups that endorsed the bill can use the political moment to press insurers for interim improvements in prior authorization turnaround times, arguing that public reporting is coming and it’s in insurers’ interest to get house in order early.